Regulation of TNF-α by 1α,25-dihydroxyvitamin D3 in human macrophages from CAPD patients

被引:52
作者
Cohen, ML
Douvdevani, A
Chaimovitz, C
Shany, S
机构
[1] Ben Gurion Univ Negev, Soroka Med Ctr, Fac Hlth Sci, Dept Clin Biochem, IL-84105 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Soroka Med Ctr, Fac Hlth Sci, Dept Nephrol, IL-84105 Beer Sheva, Israel
关键词
cytokines; inflammation; immune system; CAPD; peritonitis; cell growth; vitamin D;
D O I
10.1046/j.1523-1755.2001.00467.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background We have previously reported that 1 alpha ,25-dihydroxyvitamin D-3 [1 alpha ,25(OH)(2)D-3] accumulates in the dialysis fluid of uremic patients treated by continuous ambulatory peritoneal dialysis (CAPD). It has been reported that this metabolite regulates the production of cytokines by monocytes/macrophages. Since tumor necrosis factor-alpha (TNF-alpha) initiates an inflammatory cascade during peritonitis, the aim of the present study was to investigate the effect of 1 alpha ,25(OH)(2)D-3 on the production of TNF-alpha by human peritoneal macrophages (HPMs). Methods. HPMs were obtained from patients on CAPD. Cells were incubated with various concentrations of 1 alpha ,25(OH)(2)D-3, 1 alpha ,24(S) dihydroxyvitamin D-2 [1 alpha ,24(S)(OH)(2)D-2] Or 25-hydroxyvitamin D-3 (25-OH-D-3) for 16 hours. This was followed by lipopolysaccharide (LPS; 1 mug/mL) incubation for 2.5 to 6 hours. TNF-alpha protein production was determined by enzyme-linked immunosorbent assay. TNF-alpha mRNA was assayed by the reverse transcriptase-polymerase chain reaction procedure, using internal synthetic mRNA standards for quantitative results. Results. Incubation of HPMs with 1 alpha ,25(OH)(2)D-3 prior to stimulation with LPS dose dependently inhibited the expression of TNF-alpha on both mRNA and protein levels. Similar results were obtained with the less calcemic vitamin D-2 analogue 1 alpha ,24(S)(OH)(2)D-2. Incubation of HPMs with 25-OH-D-3 also revealed a down-regulation of TNF-alpha. expression. Since this down-regulatory effect was blocked by ketoconazole, it is likely that this effect was caused by the conversion of 25-OH-D-3 into 1 alpha ,25(OH)(2)D-3 by HPMs. Conclusions. 1 alpha ,25(OH)(2)D-3 has a potent inhibitory effect on the production of TNF-alpha by LPS-activated HPMs. We hypothesize that 1 alpha ,25(OH)(2)D-3 may constitute a regulatory mechanism that, by controlling the intensity of the inflammatory response of the peritoneum, will moderate tissue damage during peritonitis.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 50 条
[31]   1α,25-dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cells [J].
Bessler, Hanna ;
Djaldetti, Meir .
BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (06) :428-432
[32]   The effects of 1α,25-dihydroxyvitamin D3 on the expression of DNA replication genes [J].
Eelen, G ;
Verlinden, L ;
Van Camp, M ;
Van Hummelen, P ;
Marchal, K ;
De Moor, B ;
Mathieu, C ;
Carmeliet, G ;
Bouillon, R ;
Verstuyf, A .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (01) :133-146
[33]   Effects of 1, 25-Dihydroxyvitamin D3 on Experimental Autoimmune Myocarditis in Mice [J].
Hu, Fen ;
Yan, Lianhua ;
Lu, Shuai ;
Ma, Wenhan ;
Wang, Ya ;
Wei, Yuzhen ;
Yan, Xiaofei ;
Zhao, Xin ;
Chen, Zhijian ;
Wang, Zhaohui ;
Cheng, Bo .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (06) :2219-2229
[34]   1, 25-Dihydroxyvitamin D3 alters ectonucleotidase expression and activity in human cutaneous melanoma cells [J].
Bagatini, Margarete Dulce ;
Bertolin, Kalyne ;
Bridi, Alessandra ;
Pelinson, Luana Paula ;
Rosa Bonadiman, Beatriz da Silva ;
Pillat, Michele Mainardi ;
Dias Goncalves, Paulo Bayard ;
Ulrich, Henning ;
Chitolina Schetinger, Maria Rosa ;
Morsch, Vera Maria .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (06) :9992-10000
[35]   Differential apoptotic response of human melanoma cells to 1α,25-dihydroxyvitamin D3 and its analogues [J].
Carina Danielsson ;
Karin Fehsel ;
Patsie Polly ;
Carsten Carlberg .
Cell Death & Differentiation, 1998, 5 :946-952
[36]   Synthesis of 1α25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1α25,-dihydroxyvitamin D3 antagonist [J].
Kato, Y ;
Nakano, Y ;
Sano, H ;
Tanatani, A ;
Kobayashi, H ;
Shimazawa, R ;
Koshino, H ;
Hashimoto, Y ;
Nagasawa, K .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (10) :2579-2583
[37]   Evidence that both 1α,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization [J].
van Driel, M. ;
Koedam, M. ;
Buurman, C. J. ;
Roelse, M. ;
Weyts, F. ;
Chiba, H. ;
Uitterlinden, A. G. ;
Pols, H. A. P. ;
Van Leeuwen, J. P. T. M. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (03) :922-935
[38]   Functions of 1α,25-dihydroxyvitamin D3 in mammary gland:: from normal development to breast cancer [J].
Narvaez, CJ ;
Zinser, G ;
Welsh, J .
STEROIDS, 2001, 66 (3-5) :301-308
[39]   The ASAP2 gene is a primary target of 1,25-dihydroxyvitamin D3 in human monocytes and macrophages [J].
Seuter, Sabine ;
Ryynanen, Jussi ;
Carlberg, Carsten .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2014, 144 :12-18
[40]   Novel Gemini analogs of 1α,25-dihydroxyvitamin D3 with enhanced transcriptional activity [J].
Weyts, FA ;
Dhawan, P ;
Zhang, XY ;
Bishop, JE ;
Uskokovic, MR ;
Ji, Y ;
Studzinski, GP ;
Norman, AW ;
Christakos, S .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (07) :1327-1336